FDA approves most expensive drug yet at $3.5 million per dose
CHICOPEE, Mass. (WWLP)- The FDA has just approved the most expensive drug on the market to date. The drug, known as Hemgenix, costs $3.5 million per dose and is administered to patients with the rare disorder Hemophilia B.
Hemophilia B is the rarer form of the blood clotting disorder resulting from insufficient amounts of a protein called Protein IX. Most patients with hemophilia B are men and about 1 in every 40,000 people has the disorder. Women are often carriers, displaying no symptoms but passing the disorder on to their children.
Small cuts or bruises can be life-threatening, and many people need treatments once or more a week to prevent serious bleeding. Left untreated, the condition can cause bleeding that seeps into joints and internal organs, including the brain.
Currently, patients receive frequent, expensive IVs of a protein that helps blood clot and prevent bleeding. Hemgenix is a gene therapy drug that is given in one dose via IV infusion.
https://www.msn.com/en-us/health/medical/fda-approves-most-expensive-drug-yet-at-3-5-million-per-dose/ar-AA14Cbha
Expensive because the affliction is so rare. Good luck in getting your insurance to pay for it.